Phase I Study of GW642444M in Healthy Japanese Male Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This is a randomized, double blind, placebo controlled, parallel-group, 7 day repeat dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled dose of GW642444M from a novel dry powder device in healthy Japanese male subjects.
Epistemonikos ID: 32b347c9db43fce0c8fe6af7225e689cb5121810
First added on: May 05, 2024